...
首页> 外文期刊>Clinical neurology and neurosurgery >The role of vascular endothelial growth factor and vascular endothelial growth inhibitor in clinical outcome of traumatic brain injury
【24h】

The role of vascular endothelial growth factor and vascular endothelial growth inhibitor in clinical outcome of traumatic brain injury

机译:血管内皮生长因子和血管内皮生长抑制剂在创伤性脑损伤的临床结果中的作用

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives: Tumor necrosis factor superfamily-15 (TNFSF15) also known as vascular endothelial growth inhibitor (VEGI) is a cytokine that modulates anti-angiogenesis and inflammation. Vascular endothelial growth factor (VEGF) promotes angiogenesis and vascular permeability following traumatic brain injury (TBI). The balance of VEGF and VEGI may play a key role in the maintenance of vascular and immune system homeostasis in the brain. However, the dynamic changes of circulating VEGF and VEGI after traumatic brain injury (TBI) and the correlation between plasma VEGF and plasma VEGI remains obscure. In this study, we were to investigate whether circulating VEGF and VEGI can be used as prognostic markers for patients with TBI.
机译:目的:肿瘤坏死因子超家族-15(TNFSF15)也称为血管内皮生长抑制剂(VEGI)是一种调节抗血管生成和炎症的细胞因子。 血管内皮生长因子(VEGF)促进创伤性脑损伤(TBI)后的血管生成和血管渗透性。 VEGF和VEGI的平衡可能在维持大脑中维持血管和免疫系统稳态中发挥关键作用。 然而,创伤性脑损伤(TBI)后循环VEGF和VEGI的动态变化及等离子体VEGF和血浆VEGI之间的相关性仍然模糊不清。 在这项研究中,我们研究了循环VEGF和VEGI是否可以用作TBI患者的预后标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号